Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$140.68 - $188.02 $457,913 - $612,005
-3,255 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$247.59 - $304.47 $77,990 - $95,908
315 Added 10.71%
3,255 $862,000
Q3 2021

Nov 04, 2021

BUY
$194.77 - $324.21 $6,816 - $11,347
35 Added 1.2%
2,940 $850,000
Q2 2021

Aug 09, 2021

BUY
$165.87 - $220.95 $481,852 - $641,859
2,905 New
2,905 $580,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.95B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Knowledge Leaders Capital, LLC Portfolio

Follow Knowledge Leaders Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knowledge Leaders Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knowledge Leaders Capital, LLC with notifications on news.